Wilkins H Jeffrey 4
4 · Avalo Therapeutics, Inc. · Filed Dec 14, 2021
Insider Transaction Report
Form 4
Wilkins H Jeffrey
Chief Medical Officer
Transactions
- Purchase
Common Stock
2021-12-10$1.57/sh+6,371$10,002→ 33,373 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.